Inhibition of the ubiquitin-proteasome system by natural products for cancer therapy.
about
Cnidarians as a source of new marine bioactive compounds--an overview of the last decade and future steps for bioprospectingRecent advances in antimultiple myeloma drug development.Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future.Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.Crystal structure of N-{N-[N-acetyl-(S)-leuc-yl]-(S)-leuc-yl}norleucinal (ALLN), an inhibitor of proteasome.From bortezomib to other inhibitors of the proteasome and beyond.Copy number variation of E3 ubiquitin ligase genes in peripheral blood leukocyte and colorectal cancer.Exploiting nature's rich source of proteasome inhibitors as starting points in drug development.Development of Proteasome Inhibitors as Therapeutic Drugs.Activation of AMP-activated protein kinase and phosphorylation of glycogen synthase kinase3 β mediate ursolic acid induced apoptosis in HepG2 liver cancer cells.Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome system.Variabines A and B: new β-carboline alkaloids from the marine sponge Luffariella variabilis.Three new polyketides from marine-derived fungus Penicillium citrinum SCSGAF 0167.
P2860
Q26859686-EFC20EDF-FEA2-4C96-BF23-E17486AD28FBQ33416297-5FF6A467-C061-45FC-86C9-3B3B3361DBA8Q34195083-606E89DB-CB60-41F8-8940-4EF08E05AC08Q34788381-81F444A0-FB44-4E87-BDBF-668FC5ECFC62Q35150882-E9974434-B2D2-4618-AFC8-8CCBF4A7D0C8Q36852277-F05D4885-494F-4126-85CA-A0CA20FEEACDQ37096504-05AE5C44-4A49-4833-B3EF-FB9117111E8CQ37951013-66E313F3-5488-4156-9F8A-8665C49501DDQ38075795-8BFBC01E-5EDD-44C9-98A6-F19250FC2046Q44187571-1D91AB13-F1F3-4930-83B7-0D7CDC016D08Q45229028-C5CF8BB8-2567-4401-A9F4-4042217D0629Q50981919-50045F66-2E21-4C22-8FD2-3E2617FE88D5Q51505515-F88F2CF2-F03B-4B3F-8A66-84C6B93E3AEE
P2860
Inhibition of the ubiquitin-proteasome system by natural products for cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition of the ubiquitin-proteasome system by natural products for cancer therapy.
@en
Inhibition of the ubiquitin-proteasome system by natural products for cancer therapy.
@nl
type
label
Inhibition of the ubiquitin-proteasome system by natural products for cancer therapy.
@en
Inhibition of the ubiquitin-proteasome system by natural products for cancer therapy.
@nl
prefLabel
Inhibition of the ubiquitin-proteasome system by natural products for cancer therapy.
@en
Inhibition of the ubiquitin-proteasome system by natural products for cancer therapy.
@nl
P356
P1433
P1476
Inhibition of the ubiquitin-proteasome system by natural products for cancer therapy.
@en
P2093
Hideyoshi Yokosawa
P304
P356
10.1055/S-0029-1240901
P577
2010-02-25T00:00:00Z